Key result
Cardiac resynchronization therapy in adults with congenital heart disease resulted in a 77% response rate (improvement in NYHA class or ventricular function) over a median follow-up of 2.6 years.
Why the study?
Does cardiac resynchronization therapy improve NYHA functional class or systemic ventricular ejection fraction in adults with congenital heart disease?
Cohort (n=48)
Yes
Does cardiac resynchronization therapy improve NYHA functional class or systemic ventricular ejection fraction in adults with congenital heart disease?
Cardiac resynchronization therapy is feasible and effective in adults with congenital heart disease, yielding a 77% clinical or echocardiographic response rate.
No takes yet. Share an insight, caveat, or question.
CRT was associated with response in adult CHD; hypothesis-generating and should not yet change practice.
Koyak et al. (2016) conducted a cohort in Congenital heart disease (n=48). Cardiac resynchronization therapy (CRT) was evaluated on Response to CRT (improvement in NYHA functional class and/or systemic ventricular ejection fraction by at least one category). Cardiac resynchronization therapy in adults with congenital heart disease resulted in a 77% response rate (improvement in NYHA class or ventricular function) over a median follow-up of 2.6 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: